How much did Byhealth Co achieve in EBIT for the current year?
In the current year, Byhealth Co has achieved an EBIT of 2.04 B CNY.
Byhealth Co EBIT 2024
Byhealth Co EBIT
2.04 B CNY
Ticker
300146.SZ
ISIN
CNE100000Y84
In 2024, Byhealth Co's EBIT was 2.04 B CNY, a 2.99% increase from the 1.98 B CNY EBIT recorded in the previous year.
The Byhealth Co EBIT history
| YEAR | EBIT (undefined CNY) |
|---|---|
| 2026e | 2.66 |
| 2025e | 2.34 |
| 2024e | 2.04 |
| 2023 | 1.98 |
| 2022 | 1.66 |
| 2021 | 1.89 |
| 2020 | 1.4 |
| 2019 | 1.2 |
| 2018 | 1.09 |
| 2017 | 0.76 |
| 2016 | 0.56 |
| 2015 | 0.64 |
| 2014 | 0.51 |
| 2013 | 0.47 |
| 2012 | 0.3 |
| 2011 | 0.18 |
| 2010 | 0.11 |
| 2009 | 0.06 |
| 2008 | 0.04 |
| 2007 | 0.02 |
Byhealth Co Revenue, EBIT, Net Income CNE100000Y84 ·
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Byhealth Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Byhealth Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Byhealth Co’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Byhealth Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Byhealth Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Byhealth Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Byhealth Co’s growth potential.
Byhealth Co Revenue, EBIT and net profit per share
| Date | Byhealth Co Revenue | Byhealth Co EBIT | Byhealth Co Net Income |
|---|---|---|---|
| 2026e | 12.39 B undefined | 2.66 B undefined | 1.6 B undefined |
| 2025e | 11.29 B undefined | 2.34 B undefined | 1.43 B undefined |
| 2024e | 10.3 B undefined | 2.04 B undefined | 1.27 B undefined |
| 2023 | 9.41 B undefined | 1.98 B undefined | 1.75 B undefined |
| 2022 | 7.86 B undefined | 1.66 B undefined | 1.39 B undefined |
| 2021 | 7.43 B undefined | 1.89 B undefined | 1.75 B undefined |
| 2020 | 6.09 B undefined | 1.4 B undefined | 1.52 B undefined |
| 2019 | 5.26 B undefined | 1.2 B undefined | -358.4 M undefined |
| 2018 | 4.35 B undefined | 1.09 B undefined | 999.3 M undefined |
| 2017 | 3.11 B undefined | 759 M undefined | 762.8 M undefined |
| 2016 | 2.31 B undefined | 557.1 M undefined | 535.2 M undefined |
| 2015 | 2.27 B undefined | 637.5 M undefined | 635.5 M undefined |
| 2014 | 1.71 B undefined | 510.4 M undefined | 502.6 M undefined |
| 2013 | 1.48 B undefined | 468.6 M undefined | 421.7 M undefined |
| 2012 | 1.07 B undefined | 295.6 M undefined | 280.4 M undefined |
| 2011 | 658 M undefined | 182.2 M undefined | 186.4 M undefined |
| 2010 | 346.1 M undefined | 106.3 M undefined | 92.1 M undefined |
| 2009 | 205.3 M undefined | 61.6 M undefined | 52.2 M undefined |
| 2008 | 141.9 M undefined | 36.3 M undefined | 26.7 M undefined |
| 2007 | 66.9 M undefined | 17.2 M undefined | 12.1 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2007 | 66.9 M CNY | 17.2 M CNY | 12.1 M CNY |
| 2008 | 141.9 M CNY | 36.3 M CNY | 26.7 M CNY |
| 2009 | 205.3 M CNY | 61.6 M CNY | 52.2 M CNY |
| 2010 | 346.1 M CNY | 106.3 M CNY | 92.1 M CNY |
| 2011 | 658 M CNY | 182.2 M CNY | 186.4 M CNY |
| 2012 | 1.07 B CNY | 295.6 M CNY | 280.4 M CNY |
| 2013 | 1.48 B CNY | 468.6 M CNY | 421.7 M CNY |
| 2014 | 1.71 B CNY | 510.4 M CNY | 502.6 M CNY |
| 2015 | 2.27 B CNY | 637.5 M CNY | 635.5 M CNY |
| 2016 | 2.31 B CNY | 557.1 M CNY | 535.2 M CNY |
| 2017 | 3.11 B CNY | 759 M CNY | 762.8 M CNY |
| 2018 | 4.35 B CNY | 1.09 B CNY | 999.3 M CNY |
| 2019 | 5.26 B CNY | 1.2 B CNY | -358.4 M CNY |
| 2020 | 6.09 B CNY | 1.4 B CNY | 1.52 B CNY |
| 2021 | 7.43 B CNY | 1.89 B CNY | 1.75 B CNY |
| 2022 | 7.86 B CNY | 1.66 B CNY | 1.39 B CNY |
| 2023 | 9.41 B CNY | 1.98 B CNY | 1.75 B CNY |
| 2024e | 10.3 B CNY | 2.04 B CNY | 1.27 B CNY |
| 2025e | 11.29 B CNY | 2.34 B CNY | 1.43 B CNY |
| 2026e | 12.39 B CNY | 2.66 B CNY | 1.6 B CNY |
Byhealth Co stock margins CNE100000Y84 ·
The Byhealth Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Byhealth Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Byhealth Co.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Byhealth Co's sales revenue. A higher gross margin percentage indicates that the Byhealth Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Byhealth Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Byhealth Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Byhealth Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Byhealth Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Byhealth Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Byhealth Co Margin History
| Byhealth Co Gross margin | Byhealth Co Profit margin | Byhealth Co EBIT margin | Byhealth Co Profit margin |
|---|---|---|---|
| 2026e | 68.76 % | 21.48 % | 12.95 % |
| 2025e | 68.76 % | 20.69 % | 12.67 % |
| 2024e | 68.76 % | 19.78 % | 12.31 % |
| 2023 | 68.76 % | 21.03 % | 18.56 % |
| 2022 | 68.12 % | 21.11 % | 17.63 % |
| 2021 | 65.81 % | 25.38 % | 23.6 % |
| 2020 | 62.67 % | 22.96 % | 25.01 % |
| 2019 | 65.37 % | 22.81 % | -6.81 % |
| 2018 | 67.18 % | 25.14 % | 22.97 % |
| 2017 | 66.94 % | 24.4 % | 24.52 % |
| 2016 | 64.11 % | 24.13 % | 23.18 % |
| 2015 | 66.17 % | 28.13 % | 28.05 % |
| 2014 | 64.9 % | 29.94 % | 29.48 % |
| 2013 | 64.65 % | 31.62 % | 28.45 % |
| 2012 | 63.3 % | 27.71 % | 26.29 % |
| 2011 | 63.02 % | 27.69 % | 28.33 % |
| 2010 | 63.51 % | 30.71 % | 26.61 % |
| 2009 | 62.2 % | 30 % | 25.43 % |
| 2008 | 59.41 % | 25.58 % | 18.82 % |
| 2007 | 53.81 % | 25.71 % | 18.09 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2007 | 53.81 % | 25.71 % | 18.09 % |
| 2008 | 59.41 % | 25.58 % | 18.82 % |
| 2009 | 62.2 % | 30 % | 25.43 % |
| 2010 | 63.51 % | 30.71 % | 26.61 % |
| 2011 | 63.02 % | 27.69 % | 28.33 % |
| 2012 | 63.3 % | 27.71 % | 26.29 % |
| 2013 | 64.65 % | 31.62 % | 28.45 % |
| 2014 | 64.9 % | 29.94 % | 29.48 % |
| 2015 | 66.17 % | 28.13 % | 28.05 % |
| 2016 | 64.11 % | 24.13 % | 23.18 % |
| 2017 | 66.94 % | 24.4 % | 24.52 % |
| 2018 | 67.18 % | 25.14 % | 22.97 % |
| 2019 | 65.37 % | 22.81 % | -6.81 % |
| 2020 | 62.67 % | 22.96 % | 25.01 % |
| 2021 | 65.81 % | 25.38 % | 23.6 % |
| 2022 | 68.12 % | 21.11 % | 17.63 % |
| 2023 | 68.76 % | 21.03 % | 18.56 % |
| 2024e | 68.76 % | 19.78 % | 12.31 % |
| 2025e | 68.76 % | 20.69 % | 12.67 % |
| 2026e | 68.76 % | 21.48 % | 12.95 % |
Byhealth Co Aktienanalyse
What does Byhealth Co do?
Byhealth Co Ltd is a company that specializes in the manufacture and sale of dietary supplements and health products. The company was founded in 1998 in Guangzhou, China. The founder of Byhealth, Mr. Liang Guangwei, has early on specialized in the production of high-quality health products and cosmetics. As a result, Byhealth quickly became a leading company in the dietary supplement industry. The company enjoys a very good reputation, particularly in Asia, and has received multiple awards. The goal of Byhealth is to offer high-quality dietary supplements and health products that support the health and well-being of customers. The company relies on its own research and development, which guarantees a high quality of the products. Byhealth distributes its products worldwide, particularly in Asia, Europe, and North America. The company works closely with distribution partners to reach a wide customer base. To achieve this, Byhealth has developed a variety of product lines tailored to different customer needs. These include products to support the immune system, digestion, sleep, skin, metabolism, and weight loss. Byhealth pays special attention to its product line Revotropix, which is among the most well-known and popular in the industry. The products contain a variety of plant-based and natural ingredients that are supposed to alleviate symptoms of stress, pain, and depression. The products are available in various forms, such as capsules or powder. Another important area is weight loss products, which are intended to help customers control and reduce their weight. These include fat-binding tablets and products that stimulate metabolism. Byhealth strictly adheres to the highest quality standards in the production of its products. All products are produced in accordance with Good Manufacturing Practice (GMP) and other international standards. The company uses only natural ingredients to ensure that all products are safe and effective. As an innovative company, Byhealth also relies on new technologies and trends to further improve its products. For example, the company uses the latest technology for the extraction of natural ingredients to ensure a higher efficacy and purity of its products. Overall, Byhealth has earned an excellent reputation in the industry with its high-quality dietary supplements and health products. Through its research and development and the use of state-of-the-art production methods, Byhealth is able to offer a wide range of health products that help customers improve their health and well-being. Byhealth Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Byhealth Co's EBIT
Byhealth Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Byhealth Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Byhealth Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Byhealth Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Byhealth Co stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Byhealth Co.
How has the EBIT of Byhealth Co developed in recent years?
The EBIT of Byhealth Co has increased by 2.99% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Byhealth Co?
The EBIT of Byhealth Co is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Byhealth Co pay?
Over the past 12 months, Byhealth Co paid a dividend of 0.18 CNY . This corresponds to a dividend yield of about 1.33 %. For the coming 12 months, Byhealth Co is expected to pay a dividend of 0.19 CNY.
What is the dividend yield of Byhealth Co?
The current dividend yield of Byhealth Co is 1.33 %.
When does Byhealth Co pay dividends?
Byhealth Co pays a quarterly dividend. This is distributed in the months of May, May, May, May.
How secure is the dividend of Byhealth Co?
Byhealth Co paid dividends every year for the past 16 years.
What is the dividend of Byhealth Co?
For the upcoming 12 months, dividends amounting to 0.19 CNY are expected. This corresponds to a dividend yield of 1.38 %.
In which sector is Byhealth Co located?
Byhealth Co is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Byhealth Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Byhealth Co from 4/22/2024 amounting to 0.9 CNY, you needed to have the stock in your portfolio before the ex-date on 4/22/2024.
When did Byhealth Co pay the last dividend?
The last dividend was paid out on 4/22/2024.
What was the dividend of Byhealth Co in the year 2023?
In the year 2023, Byhealth Co distributed 0.7 CNY as dividends.
In which currency does Byhealth Co pay out the dividend?
The dividends of Byhealth Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Byhealth Co
Our stock analysis for Byhealth Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Byhealth Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.